- News & Analysis
Page 297
Boragen bonds with corporates in $10m series A
Bayer, Syngenta, Elanco Animal Health and Alexandria Real Estate Equities were among the investors as fungicide developer Boragen launched with $10m of funds.
Mar 6, 2017OpenText files away Sensibill in its portfolio
Sensibill, the developer of a receipt management tool for mobile banking apps, has raised $12.9m in a series A round co-led by OpenText's Enterprise Apps Fund.
Mar 6, 2017Up Pictures documents $15m investment
Legend has led a series A round for the web TV and film studio, which is now valued at $200m.
Mar 3, 2017Shumei uncovers $10m series A
Baidu Ventures and Qihoo 360 Technology are among the backers of a funding round for Shumei Technology.
Mar 2, 2017Incorta courts GV for $10m series A
GV has led a series A round for Incorta, a real-time analytics platform that reduces query times from several hours to seconds.
Mar 2, 2017Freenome manages $65m series A
The disease detection technology developer has received cash from a consortium that included GV.
Mar 2, 2017Arrakis emerges with $38m series A
Pfizer and Celgene, as well as Osage University Partners and others, have backed a $38m series A round to help launch Arrakis Therapeutics.
Feb 28, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
© 2025 Mawsonia Ltd. All rights reserved.test regLogin